EPIRUS Biopharmaceuticals Inc (EPRSQ)
0.00
USD |
OTCM |
May 03, 16:00
EPIRUS Biopharmaceuticals Total Liabilities (Quarterly): 35.18M for March 31, 2016
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2016 | 35.18M |
| December 31, 2015 | 35.90M |
| September 30, 2015 | 36.37M |
| June 30, 2015 | 28.37M |
| March 31, 2015 | 17.86M |
| December 31, 2014 | 18.98M |
| September 30, 2014 | 11.44M |
| June 30, 2014 | 2.36M |
| March 31, 2014 | 5.465M |
| December 31, 2013 | 46.17M |
| September 30, 2013 | 20.96M |
| June 30, 2013 | 23.92M |
| March 31, 2013 | 24.70M |
| December 31, 2012 | 30.35M |
| September 30, 2012 | 32.75M |
| June 30, 2012 | 32.67M |
| March 31, 2012 | 36.31M |
| December 31, 2011 | 35.97M |
| September 30, 2011 | 27.51M |
| June 30, 2011 | 28.58M |
| March 31, 2011 | 19.76M |
| December 31, 2010 | 19.67M |
| Date | Value |
|---|---|
| September 30, 2010 | 14.66M |
| June 30, 2010 | 14.10M |
| March 31, 2010 | 14.19M |
| December 31, 2009 | 35.24M |
| September 30, 2009 | 20.67M |
| June 30, 2009 | 24.56M |
| March 31, 2009 | 42.93M |
| December 31, 2008 | 47.70M |
| September 30, 2008 | 54.55M |
| June 30, 2008 | 52.10M |
| March 31, 2008 | 54.37M |
| December 31, 2007 | 54.22M |
| September 30, 2007 | 57.45M |
| June 30, 2007 | 55.81M |
| March 31, 2007 | 47.19M |
| December 31, 2006 | 48.62M |
| September 30, 2006 | 42.02M |
| June 30, 2006 | 45.81M |
| March 31, 2006 | 42.57M |
| December 31, 2005 | 37.41M |
| September 30, 2005 | 121.47M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.72M |
| Palatin Technologies Inc | 24.94M |
| iBio Inc | 24.82M |
| Theriva Biologics Inc | 15.52M |
| Oragenics Inc | 1.798M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 61.34M |
| Shareholders Equity (Quarterly) | 26.17M |